Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2025-12-24 @ 9:40 PM
NCT ID:
NCT05052632
Eligibility Criteria:
Inclusion Criteria:
* Female patients ages 8 - 39 years of age
* Seen in CHCO or AMC outpatient clinics for any of the following reasons:
* At risk for fertility problems (Z91.89)
* Encounter for fertility preservation counseling (Z31.62)
* Primary ovarian insufficiency
* Premature ovarian failure/premature menopause
* Diminished ovarian reserve
* At least 12 months post-completion of chemotherapy and/or radiation
* History of a fertility-threatening diagnosis receiving chemotherapy; radiation; or surgery to the reproductive organs for malignancy, including but not limited to:
* Any type of cancer/malignancy
* Rheumatoid arthritis
* Systemic lupus erythematosus
* Aplastic anemia
* Fanconi anemia
* Diamond-Blackfan syndrome
* Hurler syndrome
* Other autoimmune conditions
Exclusion Criteria:
* Disorders of sexual development (i.e., gonadal dysgenesis, Turner syndrome/mosaicism, etc.)
* History of bilateral oophorectomy
* Transgender patients not receiving chemotherapy; radiation; or surgery to the reproductive organs for malignancy
* Inability to consent/assent
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
8 Years
Maximum Age:
39 Years
Study:
NCT05052632
Study Brief:
Protocol Section:
NCT05052632